NYSE:FMS - Fresenius Medical Care AG & Co. Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $38.56 -0.25 (-0.64 %) (As of 01/23/2020 10:31 AM ET) Add Compare Today's Range$38.55Now: $38.57▼$38.7350-Day Range$35.65MA: $36.82▼$38.8152-Week Range$31.63Now: $38.57▼$42.75Volume25,958 shsAverage Volume339,608 shsMarket Capitalization$23.36 billionP/E Ratio16.27Dividend Yield1.16%Beta1.45 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNYSE:FMS Previous Symbol CUSIPN/A CIK1333141 Webhttp://www.freseniusmedicalcare.com/ Phone49-6172-608-2522Debt Debt-to-Equity Ratio0.75 Current Ratio0.98 Quick Ratio0.75Price-To-Earnings Trailing P/E Ratio16.27 Forward P/E Ratio16.07 P/E Growth2.75 Sales & Book Value Annual Sales$19.44 billion Price / Sales1.20 Cash Flow$3.66 per share Price / Cash Flow10.55 Book Value$24.83 per share Price / Book1.55Profitability EPS (Most Recent Fiscal Year)$2.27 Net Income$2.34 billion Net Margins7.47% Return on Equity9.92% Return on Assets4.22%Miscellaneous Employees112,658 Outstanding Shares605,660,000Market Cap$23.36 billion Next Earnings Date2/19/2020 (Estimated) OptionableOptionable Receive FMS News and Ratings via Email Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. FMS Rates by TradingView Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions What is Fresenius Medical Care AG & Co.'s stock symbol? Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS." How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co. declared an annual dividend on Thursday, May 9th. Stockholders of record on Monday, May 20th will be given a dividend of $0.6551 per share on Friday, May 31st. This represents a dividend yield of 1.59%. The ex-dividend date is Friday, May 17th. This is a boost from Fresenius Medical Care AG & Co.'s previous annual dividend of $0.44. View Fresenius Medical Care AG & Co.'s Dividend History. How were Fresenius Medical Care AG & Co.'s earnings last quarter? Fresenius Medical Care AG & Co. (NYSE:FMS) posted its earnings results on Tuesday, October, 29th. The company reported $0.67 EPS for the quarter, topping the Zacks' consensus estimate of $0.59 by $0.08. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.72 billion. Fresenius Medical Care AG & Co. had a net margin of 7.47% and a return on equity of 9.92%. View Fresenius Medical Care AG & Co.'s Earnings History. When is Fresenius Medical Care AG & Co.'s next earnings date? Fresenius Medical Care AG & Co. is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Fresenius Medical Care AG & Co.. What price target have analysts set for FMS? 10 analysts have issued 12-month price objectives for Fresenius Medical Care AG & Co.'s stock. Their forecasts range from $40.23 to $54.00. On average, they anticipate Fresenius Medical Care AG & Co.'s share price to reach $46.68 in the next year. This suggests a possible upside of 21.0% from the stock's current price. View Analyst Price Targets for Fresenius Medical Care AG & Co.. What is the consensus analysts' recommendation for Fresenius Medical Care AG & Co.? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Fresenius Medical Care AG & Co.. Has Fresenius Medical Care AG & Co. been receiving favorable news coverage? Press coverage about FMS stock has trended somewhat positive on Thursday, according to InfoTrie. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Fresenius Medical Care AG & Co. earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Fresenius Medical Care AG & Co.. Are investors shorting Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co. saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 397,100 shares, an increase of 20.6% from the November 28th total of 329,200 shares. Based on an average daily trading volume, of 202,400 shares, the short-interest ratio is presently 2.0 days. Approximately 0.1% of the shares of the company are short sold. View Fresenius Medical Care AG & Co.'s Current Options Chain. Who are some of Fresenius Medical Care AG & Co.'s key competitors? Some companies that are related to Fresenius Medical Care AG & Co. include Davita (DVA), Progyny (PGNY), Tivity Health (TVTY), HemaCare (HEMA), American Renal Associates (ARA), Catasys (CATS), Emmaus Life Sciences (EMMA), Baudax Bio (BXRX), Caladrius Biosciences (CLBS), Pacific Health Care Organization (PFHO), BioRestorative Therapies (BRTX) and American Caresource (GNOW). What other stocks do shareholders of Fresenius Medical Care AG & Co. own? Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. investors own include Petra Diamonds (PDL), Energy Transfer LP Unit (ET), AT&T (T), Ford Motor (F), Teva Pharmaceutical Industries (TEVA), Abbott Laboratories (ABT), CBL & Associates Properties (CBL), Centurylink (CTL), Davita (DVA) and Cigna (CI). Who are Fresenius Medical Care AG & Co.'s key executives? Fresenius Medical Care AG & Co.'s management team includes the folowing people: Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 64)Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 64)Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 60)Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 47)Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 57) Who are Fresenius Medical Care AG & Co.'s major shareholders? Fresenius Medical Care AG & Co.'s stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Campbell & CO Investment Adviser LLC (0.00%) and Cascade Investment Advisors Inc. (0.00%). Which major investors are buying Fresenius Medical Care AG & Co. stock? FMS stock was acquired by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC and Cascade Investment Advisors Inc.. How do I buy shares of Fresenius Medical Care AG & Co.? Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Fresenius Medical Care AG & Co.'s stock price today? One share of FMS stock can currently be purchased for approximately $38.57. How big of a company is Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co. has a market capitalization of $23.36 billion and generates $19.44 billion in revenue each year. The company earns $2.34 billion in net income (profit) each year or $2.27 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 112,658 workers across the globe.View Additional Information About Fresenius Medical Care AG & Co.. What is Fresenius Medical Care AG & Co.'s official website? The official website for Fresenius Medical Care AG & Co. is http://www.freseniusmedicalcare.com/. How can I contact Fresenius Medical Care AG & Co.? Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-608-2522 or via email at [email protected] MarketBeat Community Rating for Fresenius Medical Care AG & Co. (NYSE FMS)Community Ranking: 1.9 out of 5 ()Outperform Votes: 321 (Vote Outperform)Underperform Votes: 526 (Vote Underperform)Total Votes: 847MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2020 by MarketBeat.com StaffFeatured Article: How can investors find ex-dividend dates?
